{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih252zj7zvp6w5oxbghjlf3jombukuqlu2qrxnnioa2roz4ncjafm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mfld5zysl322"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidouddng5levbshbzpnqvuisqnekkr3xap5ox4oij6nmk6odaygfy"
    },
    "mimeType": "image/jpeg",
    "size": 639297
  },
  "path": "/news/2026-02-fda-customized-drugs-therapies-rare.html",
  "publishedAt": "2026-02-23T22:20:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Medical economics"
  ],
  "textContent": "Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the pharmaceutical industry has long considered unprofitable.",
  "title": "FDA proposes new system for approving customized drugs and therapies for rare diseases"
}